How beliefs affect hallucinations in Parkinson's disease
Part of Brain & nervous system clinical trials.
This study looks at how your past experiences and expectations might influence visual hallucinations if you have Parkinson's disease. It involves cognitive tests and compares people with and without hallucinations, as well as healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have Parkinson's disease (with or without visual hallucinations) OR you are a healthy volunteer.
- You are able to do thinking and memory tests (like questionnaires).
- You do not have dementia.
- You are not currently in another drug trial.
- If you are a healthy volunteer, you have no history of diagnosed brain or nerve disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how electrical signals in the brain relate to psychiatric symptoms (like hallucinations, compulsive behaviors, or anxiety) in people with Parkinson's disease who have already had deep brain stimulation surgery. Understanding these connections may help doctors better treat these challenging symptoms.
This study looks at how people with schizophrenia process sensory information and make predictions. It aims to understand disruptions in these processes to improve future treatments.
This study uses brain scans (MRI) to look at a part of the brain called the inferior colliculi in people with schizophrenia who hear voices. The goal is to learn more about why auditory hallucinations happen, which could lead to better treatments in the future.
This study uses brain scans to understand how people with Parkinson's disease process social cues, like faces and emotions. It may help researchers learn more about how Parkinson's affects social thinking.
This trial tests whether a gentle brain stimulation technique called HD-tDCS can help reduce hallucinations in people with schizophrenia. It is for those who still have frequent hallucinations despite trying standard medications.
This study compares two drugs, pimavanserin and quetiapine, to see which works better for hallucinations or delusions caused by Parkinson's disease. The goal is to help patients manage these symptoms more effectively.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.